It has been our great pleasure to interview Iñaki Ochoa, head of the Research Group with which we collaborate to develop the latest technologies in Cell Culture.
It is a group specialized in oncology; that is, they perform treatments for cancer. The group is known for having developed the most advanced model in the world of glioblastoma; one of the most dangerous cancers.
Let´s see what he has to tell us!
microLIQUID: Problems encountered with conventional Cell Culture methods, and the solutions offered by Microfluidic Cell Culture:
Iñaki Ochoa: The conventional Cell Culture methods that are used today are based mainly on two-dimensional cultures performed on plastic plates. The cells are placed or “planted” at the bottom of these plates. To provide them with nutrients, a liquid, or culture medium, is added on top of them. This liquid provides the necessary nutrients. These plates require a gaseous connection to the outside in order to access the essential gases (such as oxygen) to maintain viable cells. As can easily be concluded, our body is not two-dimensional, nor do our cells live in isolatiom from each other. Under current culture conditions, the cells lack an environment similar to that of our body. Cells in the laboratory do not grow under three-dimensional conditions, they have an excess of essential elements (nutrients, oxygen, etc.) and, in addition, they lack interaction with other cell types for in vivo communication.
microLIQUID: Advantage of the Microfluidic Cell Culture:
For another year, microLIQUID will be exhibiting at AACC 2018 (Annual Scientific Meeting & Clinical Lab Expo) which will take place at McCormick Place, Chicago, IL, USA (July 31-August 2).
On behalf of our company, if you are attending to the event, we want to take advantage to have a meeting with you in order to talk about our common interests.
See you soon!
The use of durable replica moulds with high-feature resolution has been proposed as an inexpensive and convenient route for the manufacture of microstructured materials. A simple and fast duplication method, it involves the use of a master mould to create durable polymer replicas, using polydimethylsiloxane (PDMS). The application of PDMS offers numerous advantages due to its intrinsic properties such as its biocompatibility, affordable price, transparency (240nm-1100nm) as well as its low autofluorescence. The replica process enables fast and easy manufacturing since it can be covalently stuck to a glass substrate, using plasma treatment to form sealed microfluidic devices. The replica process is clean and precise, while multiple replications can be obtained from one master. This dramatically decreases both the expenditure and the time required to create specific patterns that need to be used consistently in the creation of various devices.
microLIQUID manufactures polymer SU-8 master moulds on silicon wafers, which are widely used to produce microfluidic disposables in the development and prototyping stage. In addition, we generate series of PDMS copies with excellent reproducibility and precision. microLIQUID offers high resolution moulds with a standard deviation of under 2%. microLIQUID is working in applications such as droplet generation for PCR diagnostics, single-cell analysis and high throughput screening among others. The moulds are highly reusable since we offer several treatments to increase the service life of the mould. This replica method will help you choose the optimum design for your product prior to scaling up to mass production. Indeed, more than 50 companies all over the world have already done so.
The company is now celebrating a decade working on the design and manufacture of novel microfluidic products for our customers; we are proud and delighted to have made it this far, and excited about the future!
During this time, we´ve grown in many ways, for example by increasing the number of employees and clients, as well as boosting revenues. We have collaborated successfully in more than 300 microfluidic projects around the world, doubling our turnover since 2014 and we have gained vast experience in this business dimension. In addition, we develop new value propositions to our customers, offering unique complete value chain solutions from complex microfluidic consumables that can be processed on our own design automated instrumentation (e.g. Point of Care instruments).
Since its establishment, microLIQUID has focused on delivering quality to its customers and fulfilling their expectations. This is the reason why so many of our clients and partners trust our professionalism and appreciate the individual approach we provide.
We are grateful to all those who have worked with us and have helped us over these last 10 years to develop our company. microLIQUID´s success would not have come to fruition had it not been for their unwavering support.
We are optimistic about what lies ahead and are very confident that we will be able to help many more future customers around the world to manufacture solutions based on our microfluidics and automated instrument solutions in fields such as rapid testing, immuno-oncology, NGS and Precision medicine, liquid biopsy and drug delivery among others.
We would like to thank you for devoting some of your time in visiting our booth at Compamed, held in Düsseldorf, DE, from the 13th to the 16th of November of 2017. We hope that you had a good time and enjoyed your visit to the city.
It was our pleasure and honor, and we enjoyed many inspiring conversations. Moreover, we were impressed by the number of visitors and the great interest in our products.
In case we weren’t able to answer some of your questions about our products and services while you were there, we encourage you to contact us at the following email adress: [email protected]
We look forward to being able to be of service to you.
microLIQUID will be at Compamed 2017 this November 13-16 in Düseldorf, Germany.
We will be pleased to invite you to join Hall 8a/F34.1, where we will be demonstrating our latest offerings and technologies (services in mass manufacturing of microfluidic components and automated instruments for the IVD and pharma sector, for example.) and we will have our top product experts on hand to answer your questions.
Looking forward to seeing you.
microLIQUID will be at the 2017 AACC Clinical Lab Expo this August 1-3 in San Diego, CA.
AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. Their leadership in education, advocacy and collaboration helps lab professionals adapt to change and do what they do best: provide vital insight and guidance so patients get the care they need.
On behalf of our company, if you are attending to AACC, we want to take advantage to have a meeting with you in order to talk about our common interests.
We will be pleased to invite you to join our booth #630, where we will be showcasing our latest offerings and technologies, and we will have our top product experts on hand to answer your questions.
Looking forward to seeing you.
Microfluidic Event in Spain
Microliquid has attended the “8th International meeting in Biotechnology “ from the 28th to the 30th of September, held in BEC (Bilbao). It is important to say that more than 850 companies went to the meeting and almost the 34% of the attending companies where international, coming from 28 different countries. Moreover, during these 3 days, there have been more than 3.300 meeting or partnerings, with more than 2.000 people of different companies taking part.
Biospain is a biennial event organized by ASEBIO, the Spanish association of Biotechnology Companies, in collaboration with other organizations, in this case, the Basque Business Development Agency. Due to the increasing international rivalry, this meeting is important for companies working in the Biotechnology field, in order to expand what they do and learn from other companies. BioSpain 2016 has had also a greater presence of USA companies and organizations, being USA the guest country in this eighth edition. People form the states of Maryland, Massachusetts, North Carolina, Pennsylvania, Texas, Virginia and Puerto Rico have attended the meeting. Moreover, this year the participation of national companies has raised, more specifically Galicia, Basque Country, Cataluña, Valencia or Baleares. Some of the topics discussed at BioSpain 2016 are oncology, Alzheimer, food, vaccine or new diagnostic methods.
Two of the members of our company have been in the meeting during the three days, trying to know more about other companies working in the same field of us, and moreover, letting them know what Microliquid does. Apart from having a stand to show what we do, Microliquid has been attending the Partnering area, where it was possible to talk to other companies, try to explain how our company works, listen to what they do, and sometimes, open new ways to work together, as a team, or helping each other.
Moreover, Microliquid makes a positive assessment of the fair, taking into account that a lot of people have attended our stand, new companies know about us, and we have been able to make new alliances with other companies.
To finish with, Ion Arocena, the director of the Spanish Association of Biotechnology Companies (Asebio), says that “We think that BioSpain 2016 has been a good representation of the sector worldwide” , and he makes a positive evaluation of those three days.